Genetic Testing-EMEA Market Status and Trend Report 2013-2023
Report Summary
Genetic Testing-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Genetic Testing industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Genetic Testing 2013-2017, and development forecast 2018-2023
Main market players of Genetic Testing in EMEA, with company and product introduction, position in the Genetic Testing market
Market status and development trend of Genetic Testing by types and applications
Cost and profit status of Genetic Testing, and marketing status
Market growth drivers and challenges
The report segments the EMEA Genetic Testing market as:
EMEA Genetic Testing Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Genetic Testing Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Newborn Screening
Diagnostic Testing
Carrier Testing
Preimplantation Genetic Diagnosis
Prenatal Diagnosis
Predictive and Presymptomatic Testing
Pharmacogenomics
EMEA Genetic Testing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Cardiology
Dermatology
Hematology
Hereditary Cancer
Immunology
Metabolic Disorders and Newborn Screening
Neurology
Ophthalmology
Pediatric Genetics
Other
EMEA Genetic Testing Market: Players Segment Analysis (Company and Product introduction, Genetic Testing Sales Volume, Revenue, Price and Gross Margin):
GeneDx
Invitae
Pathway Genomics
Counsyl Inc
Asper Biotech
GenePlanet
Courtagen Life Sciences
Gene By Gene
Natera Inc
Regulatory
GeneTests
United Gene
HI Gene
Berry Genomics
23andMe Inc
360Jiyin
Novogene
CapitalBio
Agen
Biomedlab
Biomarker
Annoroad
Aiyin Gene
Aijiyin
Repconex
Find Bio-Tech
SinoGenoMax
Gene Kang
Geeppine
BGI
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Genetic Testing-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Genetic Testing industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Genetic Testing 2013-2017, and development forecast 2018-2023
Main market players of Genetic Testing in EMEA, with company and product introduction, position in the Genetic Testing market
Market status and development trend of Genetic Testing by types and applications
Cost and profit status of Genetic Testing, and marketing status
Market growth drivers and challenges
The report segments the EMEA Genetic Testing market as:
EMEA Genetic Testing Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Genetic Testing Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Newborn Screening
Diagnostic Testing
Carrier Testing
Preimplantation Genetic Diagnosis
Prenatal Diagnosis
Predictive and Presymptomatic Testing
Pharmacogenomics
EMEA Genetic Testing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Cardiology
Dermatology
Hematology
Hereditary Cancer
Immunology
Metabolic Disorders and Newborn Screening
Neurology
Ophthalmology
Pediatric Genetics
Other
EMEA Genetic Testing Market: Players Segment Analysis (Company and Product introduction, Genetic Testing Sales Volume, Revenue, Price and Gross Margin):
GeneDx
Invitae
Pathway Genomics
Counsyl Inc
Asper Biotech
GenePlanet
Courtagen Life Sciences
Gene By Gene
Natera Inc
Regulatory
GeneTests
United Gene
HI Gene
Berry Genomics
23andMe Inc
360Jiyin
Novogene
CapitalBio
Agen
Biomedlab
Biomarker
Annoroad
Aiyin Gene
Aijiyin
Repconex
Find Bio-Tech
SinoGenoMax
Gene Kang
Geeppine
BGI
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF GENETIC TESTING
1.1 Definition of Genetic Testing in This Report
1.2 Commercial Types of Genetic Testing
1.2.1 Newborn Screening
1.2.2 Diagnostic Testing
1.2.3 Carrier Testing
1.2.4 Preimplantation Genetic Diagnosis
1.2.5 Prenatal Diagnosis
1.2.6 Predictive and Presymptomatic Testing
1.2.7 Pharmacogenomics
1.3 Downstream Application of Genetic Testing
1.3.1 Cardiology
1.3.2 Dermatology
1.3.3 Hematology
1.3.4 Hereditary Cancer
1.3.5 Immunology
1.3.6 Metabolic Disorders and Newborn Screening
1.3.7 Neurology
1.3.8 Ophthalmology
1.3.9 Pediatric Genetics
1.3.10 Other
1.4 Development History of Genetic Testing
1.5 Market Status and Trend of Genetic Testing 2013-2023
1.5.1 Asia Pacific Genetic Testing Market Status and Trend 2013-2023
1.5.2 Regional Genetic Testing Market Status and Trend 2013-2023
CHAPTER 2 ASIA PACIFIC MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Genetic Testing in Asia Pacific 2013-2017
2.2 Consumption Market of Genetic Testing in Asia Pacific by Regions
2.2.1 Consumption Volume of Genetic Testing in Asia Pacific by Regions
2.2.2 Revenue of Genetic Testing in Asia Pacific by Regions
2.3 Market Analysis of Genetic Testing in Asia Pacific by Regions
2.3.1 Market Analysis of Genetic Testing in China 2013-2017
2.3.2 Market Analysis of Genetic Testing in Japan 2013-2017
2.3.3 Market Analysis of Genetic Testing in Korea 2013-2017
2.3.4 Market Analysis of Genetic Testing in India 2013-2017
2.3.5 Market Analysis of Genetic Testing in Southeast Asia 2013-2017
2.3.6 Market Analysis of Genetic Testing in Australia 2013-2017
2.4 Market Development Forecast of Genetic Testing in Asia Pacific 2018-2023
2.4.1 Market Development Forecast of Genetic Testing in Asia Pacific 2018-2023
2.4.2 Market Development Forecast of Genetic Testing by Regions 2018-2023
CHAPTER 3 ASIA PACIFIC MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Asia Pacific Market Status by Types
3.1.1 Consumption Volume of Genetic Testing in Asia Pacific by Types
3.1.2 Revenue of Genetic Testing in Asia Pacific by Types
3.2 Asia Pacific Market Status by Types in Major Countries
3.2.1 Market Status by Types in China
3.2.2 Market Status by Types in Japan
3.2.3 Market Status by Types in Korea
3.2.4 Market Status by Types in India
3.2.5 Market Status by Types in Southeast Asia
3.2.6 Market Status by Types in Australia
3.3 Market Forecast of Genetic Testing in Asia Pacific by Types
CHAPTER 4 ASIA PACIFIC MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Genetic Testing in Asia Pacific by Downstream Industry
4.2 Demand Volume of Genetic Testing by Downstream Industry in Major Countries
4.2.1 Demand Volume of Genetic Testing by Downstream Industry in China
4.2.2 Demand Volume of Genetic Testing by Downstream Industry in Japan
4.2.3 Demand Volume of Genetic Testing by Downstream Industry in Korea
4.2.4 Demand Volume of Genetic Testing by Downstream Industry in India
4.2.5 Demand Volume of Genetic Testing by Downstream Industry in Southeast Asia
4.2.6 Demand Volume of Genetic Testing by Downstream Industry in Australia
4.3 Market Forecast of Genetic Testing in Asia Pacific by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF GENETIC TESTING
5.1 Asia Pacific Economy Situation and Trend Overview
5.2 Genetic Testing Downstream Industry Situation and Trend Overview
CHAPTER 6 GENETIC TESTING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN ASIA PACIFIC
6.1 Sales Volume of Genetic Testing in Asia Pacific by Major Players
6.2 Revenue of Genetic Testing in Asia Pacific by Major Players
6.3 Basic Information of Genetic Testing by Major Players
6.3.1 Headquarters Location and Established Time of Genetic Testing Major Players
6.3.2 Employees and Revenue Level of Genetic Testing Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 GENETIC TESTING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GeneDx
7.1.1 Company profile
7.1.2 Representative Genetic Testing Product
7.1.3 Genetic Testing Sales, Revenue, Price and Gross Margin of GeneDx
7.2 Invitae
7.2.1 Company profile
7.2.2 Representative Genetic Testing Product
7.2.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Invitae
7.3 Pathway Genomics
7.3.1 Company profile
7.3.2 Representative Genetic Testing Product
7.3.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Pathway Genomics
7.4 Counsyl Inc
7.4.1 Company profile
7.4.2 Representative Genetic Testing Product
7.4.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Counsyl Inc
7.5 Asper Biotech
7.5.1 Company profile
7.5.2 Representative Genetic Testing Product
7.5.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Asper Biotech
7.6 GenePlanet
7.6.1 Company profile
7.6.2 Representative Genetic Testing Product
7.6.3 Genetic Testing Sales, Revenue, Price and Gross Margin of GenePlanet
7.7 Courtagen Life Sciences
7.7.1 Company profile
7.7.2 Representative Genetic Testing Product
7.7.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Courtagen Life Sciences
7.8 Gene By Gene
7.8.1 Company profile
7.8.2 Representative Genetic Testing Product
7.8.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Gene By Gene
7.9 Natera Inc
7.9.1 Company profile
7.9.2 Representative Genetic Testing Product
7.9.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Natera Inc
7.10 Regulatory
7.10.1 Company profile
7.10.2 Representative Genetic Testing Product
7.10.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Regulatory
7.11 GeneTests
7.11.1 Company profile
7.11.2 Representative Genetic Testing Product
7.11.3 Genetic Testing Sales, Revenue, Price and Gross Margin of GeneTests
7.12 United Gene
7.12.1 Company profile
7.12.2 Representative Genetic Testing Product
7.12.3 Genetic Testing Sales, Revenue, Price and Gross Margin of United Gene
7.13 HI Gene
7.13.1 Company profile
7.13.2 Representative Genetic Testing Product
7.13.3 Genetic Testing Sales, Revenue, Price and Gross Margin of HI Gene
7.14 Berry Genomics
7.14.1 Company profile
7.14.2 Representative Genetic Testing Product
7.14.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Berry Genomics
7.15 23andMe Inc
7.15.1 Company profile
7.15.2 Representative Genetic Testing Product
7.15.3 Genetic Testing Sales, Revenue, Price and Gross Margin of 23andMe Inc
7.16 360Jiyin
7.17 Novogene
7.18 CapitalBio
7.19 Agen
7.20 Biomedlab
7.21 Biomarker
7.22 Annoroad
7.23 Aiyin Gene
7.24 Aijiyin
7.25 Repconex
7.26 Find Bio-Tech
7.27 SinoGenoMax
7.28 Gene Kang
7.29 Geeppine
7.30 BGI
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GENETIC TESTING
8.1 Industry Chain of Genetic Testing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF GENETIC TESTING
9.1 Cost Structure Analysis of Genetic Testing
9.2 Raw Materials Cost Analysis of Genetic Testing
9.3 Labor Cost Analysis of Genetic Testing
9.4 Manufacturing Expenses Analysis of Genetic Testing
CHAPTER 10 MARKETING STATUS ANALYSIS OF GENETIC TESTING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Genetic Testing in This Report
1.2 Commercial Types of Genetic Testing
1.2.1 Newborn Screening
1.2.2 Diagnostic Testing
1.2.3 Carrier Testing
1.2.4 Preimplantation Genetic Diagnosis
1.2.5 Prenatal Diagnosis
1.2.6 Predictive and Presymptomatic Testing
1.2.7 Pharmacogenomics
1.3 Downstream Application of Genetic Testing
1.3.1 Cardiology
1.3.2 Dermatology
1.3.3 Hematology
1.3.4 Hereditary Cancer
1.3.5 Immunology
1.3.6 Metabolic Disorders and Newborn Screening
1.3.7 Neurology
1.3.8 Ophthalmology
1.3.9 Pediatric Genetics
1.3.10 Other
1.4 Development History of Genetic Testing
1.5 Market Status and Trend of Genetic Testing 2013-2023
1.5.1 Asia Pacific Genetic Testing Market Status and Trend 2013-2023
1.5.2 Regional Genetic Testing Market Status and Trend 2013-2023
CHAPTER 2 ASIA PACIFIC MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Genetic Testing in Asia Pacific 2013-2017
2.2 Consumption Market of Genetic Testing in Asia Pacific by Regions
2.2.1 Consumption Volume of Genetic Testing in Asia Pacific by Regions
2.2.2 Revenue of Genetic Testing in Asia Pacific by Regions
2.3 Market Analysis of Genetic Testing in Asia Pacific by Regions
2.3.1 Market Analysis of Genetic Testing in China 2013-2017
2.3.2 Market Analysis of Genetic Testing in Japan 2013-2017
2.3.3 Market Analysis of Genetic Testing in Korea 2013-2017
2.3.4 Market Analysis of Genetic Testing in India 2013-2017
2.3.5 Market Analysis of Genetic Testing in Southeast Asia 2013-2017
2.3.6 Market Analysis of Genetic Testing in Australia 2013-2017
2.4 Market Development Forecast of Genetic Testing in Asia Pacific 2018-2023
2.4.1 Market Development Forecast of Genetic Testing in Asia Pacific 2018-2023
2.4.2 Market Development Forecast of Genetic Testing by Regions 2018-2023
CHAPTER 3 ASIA PACIFIC MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Asia Pacific Market Status by Types
3.1.1 Consumption Volume of Genetic Testing in Asia Pacific by Types
3.1.2 Revenue of Genetic Testing in Asia Pacific by Types
3.2 Asia Pacific Market Status by Types in Major Countries
3.2.1 Market Status by Types in China
3.2.2 Market Status by Types in Japan
3.2.3 Market Status by Types in Korea
3.2.4 Market Status by Types in India
3.2.5 Market Status by Types in Southeast Asia
3.2.6 Market Status by Types in Australia
3.3 Market Forecast of Genetic Testing in Asia Pacific by Types
CHAPTER 4 ASIA PACIFIC MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Genetic Testing in Asia Pacific by Downstream Industry
4.2 Demand Volume of Genetic Testing by Downstream Industry in Major Countries
4.2.1 Demand Volume of Genetic Testing by Downstream Industry in China
4.2.2 Demand Volume of Genetic Testing by Downstream Industry in Japan
4.2.3 Demand Volume of Genetic Testing by Downstream Industry in Korea
4.2.4 Demand Volume of Genetic Testing by Downstream Industry in India
4.2.5 Demand Volume of Genetic Testing by Downstream Industry in Southeast Asia
4.2.6 Demand Volume of Genetic Testing by Downstream Industry in Australia
4.3 Market Forecast of Genetic Testing in Asia Pacific by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF GENETIC TESTING
5.1 Asia Pacific Economy Situation and Trend Overview
5.2 Genetic Testing Downstream Industry Situation and Trend Overview
CHAPTER 6 GENETIC TESTING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN ASIA PACIFIC
6.1 Sales Volume of Genetic Testing in Asia Pacific by Major Players
6.2 Revenue of Genetic Testing in Asia Pacific by Major Players
6.3 Basic Information of Genetic Testing by Major Players
6.3.1 Headquarters Location and Established Time of Genetic Testing Major Players
6.3.2 Employees and Revenue Level of Genetic Testing Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 GENETIC TESTING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GeneDx
7.1.1 Company profile
7.1.2 Representative Genetic Testing Product
7.1.3 Genetic Testing Sales, Revenue, Price and Gross Margin of GeneDx
7.2 Invitae
7.2.1 Company profile
7.2.2 Representative Genetic Testing Product
7.2.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Invitae
7.3 Pathway Genomics
7.3.1 Company profile
7.3.2 Representative Genetic Testing Product
7.3.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Pathway Genomics
7.4 Counsyl Inc
7.4.1 Company profile
7.4.2 Representative Genetic Testing Product
7.4.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Counsyl Inc
7.5 Asper Biotech
7.5.1 Company profile
7.5.2 Representative Genetic Testing Product
7.5.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Asper Biotech
7.6 GenePlanet
7.6.1 Company profile
7.6.2 Representative Genetic Testing Product
7.6.3 Genetic Testing Sales, Revenue, Price and Gross Margin of GenePlanet
7.7 Courtagen Life Sciences
7.7.1 Company profile
7.7.2 Representative Genetic Testing Product
7.7.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Courtagen Life Sciences
7.8 Gene By Gene
7.8.1 Company profile
7.8.2 Representative Genetic Testing Product
7.8.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Gene By Gene
7.9 Natera Inc
7.9.1 Company profile
7.9.2 Representative Genetic Testing Product
7.9.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Natera Inc
7.10 Regulatory
7.10.1 Company profile
7.10.2 Representative Genetic Testing Product
7.10.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Regulatory
7.11 GeneTests
7.11.1 Company profile
7.11.2 Representative Genetic Testing Product
7.11.3 Genetic Testing Sales, Revenue, Price and Gross Margin of GeneTests
7.12 United Gene
7.12.1 Company profile
7.12.2 Representative Genetic Testing Product
7.12.3 Genetic Testing Sales, Revenue, Price and Gross Margin of United Gene
7.13 HI Gene
7.13.1 Company profile
7.13.2 Representative Genetic Testing Product
7.13.3 Genetic Testing Sales, Revenue, Price and Gross Margin of HI Gene
7.14 Berry Genomics
7.14.1 Company profile
7.14.2 Representative Genetic Testing Product
7.14.3 Genetic Testing Sales, Revenue, Price and Gross Margin of Berry Genomics
7.15 23andMe Inc
7.15.1 Company profile
7.15.2 Representative Genetic Testing Product
7.15.3 Genetic Testing Sales, Revenue, Price and Gross Margin of 23andMe Inc
7.16 360Jiyin
7.17 Novogene
7.18 CapitalBio
7.19 Agen
7.20 Biomedlab
7.21 Biomarker
7.22 Annoroad
7.23 Aiyin Gene
7.24 Aijiyin
7.25 Repconex
7.26 Find Bio-Tech
7.27 SinoGenoMax
7.28 Gene Kang
7.29 Geeppine
7.30 BGI
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GENETIC TESTING
8.1 Industry Chain of Genetic Testing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF GENETIC TESTING
9.1 Cost Structure Analysis of Genetic Testing
9.2 Raw Materials Cost Analysis of Genetic Testing
9.3 Labor Cost Analysis of Genetic Testing
9.4 Manufacturing Expenses Analysis of Genetic Testing
CHAPTER 10 MARKETING STATUS ANALYSIS OF GENETIC TESTING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
